AXSM vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

AXSM

55.2
AI Score
VS
AXSM Wins

BBIO

32.9
AI Score

Investment Advisor Scores

AXSM

55score
Recommendation
HOLD

BBIO

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AXSM BBIO Winner
Revenue 669.27M 791.36M BBIO
Net Income -128.73M -372.97M AXSM
Net Margin -19.2% -47.1% AXSM
Operating Income -124.07M -224.67M AXSM
ROE -122.1% 22.4% BBIO
ROA -15.6% -17.3% AXSM
Total Assets 826.77M 2.16B BBIO
Cash 313.86M 1.53B BBIO
Debt/Equity 1.12 -1.58 BBIO
Current Ratio 1.42 2.09 BBIO
Free Cash Flow -63.89M -313.35M AXSM

Relative Price Performance (Last 90 Days)

AXSM 1M: -12.6% · 3M: -34.6% BBIO 1M: +17.0% · 3M: -1.7%

Current Technical Phase

AXSM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.4%), weak momentum, RSI 41

RSI (14): 40.7 · Price: $141.38

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.3 · Price: $78.52

Fundamentals Snapshot

Metric AXSM BBIO
Market Cap — —
Forward P/E 41.9 -286.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.5% 1.9%
Gross Margin 0.9% 0.9%
Operating Margin -0.2% -0.4%
EPS -3.03 -3.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AXSM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.